- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
894 results
2100 Exhibit: EX2100 Leiter, LA, et al, Cardiovascular risk reduction with once wee...
Document
IPR2023-00724, No. 2100 Exhibit - EX2100 Leiter, LA, et al, Cardiovascular risk reduction with once weekly semaglutide in subjects with type 2 diabetes a post hoc analysis of gender, age, and ...
|
|
Cite Document
2065 Exhibit: EX2065 Novo Nordisk, “Annual Report 2010” February 1, 2011
Document
IPR2023-00724, No. 2065 Exhibit - EX2065 Novo Nordisk, “Annual Report 2010” February 1, 2011 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2528 Exhibit: EX2528 Eli Lilly Co, SEC Form 10 Q for the Quarter Ended March 31,...
Document
IPR2023-00724, No. 2528 Exhibit - EX2528 Eli Lilly Co, SEC Form 10 Q for the Quarter Ended March 31, 2023 Apr 27, 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2436 Exhibit: EX2436 Tanzeum® Prescribing Information rev Dec 2017
Document
IPR2023-00724, No. 2436 Exhibit - EX2436 Tanzeum® Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2494 Exhibit: EX2494 Novo Nordisk, Financial report for the period 1 January 2018...
Document
IPR2023-00724, No. 2494 Exhibit - EX2494 Novo Nordisk, Financial report for the period 1 January 2018 to 31 March 2018 May 2, 2018 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2456 Exhibit: EX2456 US Food Drug Administration, DrugsFDA, Adlyxin
Document
IPR2023-00724, No. 2456 Exhibit - EX2456 US Food Drug Administration, DrugsFDA, Adlyxin (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2479 Exhibit: EX2479 Nordrum, A, 11 Blockbuster Drugs to Watch in 2015, Intl Bus...
Document
IPR2023-00724, No. 2479 Exhibit - EX2479 Nordrum, A, 11 Blockbuster Drugs to Watch in 2015, Intl Bus Times, httpwwwibtimescom11 blockbuster drugs watch 2015 1857100 Mar 24, 2015 (P....
|
|
Cite Document
2092 Exhibit: EX2092 Das, SR, et al, Expert Consensus Decision Pathway on Nove...
Document
IPR2023-00724, No. 2092 Exhibit - EX2092 Das, SR, et al, Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes, J Am Co...
|
|
Cite Document
2104 Exhibit: EX2104 Maskery, MP, et al, Glucagon like peptide 1 receptor agonist...
Document
IPR2023-00724, No. 2104 Exhibit - EX2104 Maskery, MP, et al, Glucagon like peptide 1 receptor agonists as neuroprotective agents for ischemic stroke a systematic scoping review, J Cereb Bl...
|
|
Cite Document
3003 Exhibit: Email from Megan Raymond To Trials Cc white ptabBeel, Bryan D gre...
Document
IPR2023-00724, No. 3003 Exhibit - Email from Megan Raymond To Trials Cc white ptabBeel, Bryan D greb ptab prochnowptab jones ptab tietz pta lembo ptab Novo Semaglutide Subject IPR2023...
|
|
Cite Document
1092 Exhibit: Anstaett Declaration
Document
IPR2023-00724, No. 1092 Exhibit - Anstaett Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
1091 Exhibit: Bloodworth Declaration
Document
IPR2023-00724, No. 1091 Exhibit - Bloodworth Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
1093 Exhibit: Beel Declaration
Document
IPR2023-00724, No. 1093 Exhibit - Beel Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
3002 Exhibit: Exhibit 3002
Document
IPR2023-00724, No. 3002 Exhibit - Exhibit 3002 (P.T.A.B. Nov. 29, 2023)
|
|
Cite Document
1007 Exhibit: Declaration of Paul Dalby, PhD
Document
IPR2024-00009, No. 1007 Exhibit - Declaration of Paul Dalby, PhD (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
